Not applicableStudy completedNCT00900302What this trial is testingOX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerWho this might be right forCancer OHSU Knight Cancer Institute 98
Testing effectiveness (Phase 2)Looking for participantsNCT05269381What this trial is testingPersonalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid TumorsWho this might be right forAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+98 more Mayo Clinic 138
Testing effectiveness (Phase 2)Active Not RecruitingNCT04940299What this trial is testingTocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial CarcinomaWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced Bladder Carcinoma+39 more M.D. Anderson Cancer Center 35
Not applicableStudy completedNCT00905086What this trial is testingPsychosocial Adjustment After Radiation Therapy in Patients With CancerWho this might be right forBreast CancerCognitive/Functional EffectsColorectal Cancer+3 more Case Comprehensive Cancer Center 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07153770What this trial is testingBozitinib Combined With Chemotherapy as Radical Treatment for Stage IIA-IIIC MET-Altered Non-Small Cell Lung CancerWho this might be right forNSCLCMET Exon 14 MutationMET Activating Mutation Shanghai Pulmonary Hospital, Shanghai, China 34
Testing effectiveness (Phase 2)Active Not RecruitingNCT02498613What this trial is testingCediranib in Combination With Olaparib in Advanced Solid TumorsWho this might be right forAdvanced Malignant Solid NeoplasmMetastatic Lung Non-Small Cell CarcinomaMetastatic Lung Small Cell Carcinoma+23 more National Cancer Institute (NCI) 122
Large-scale testing (Phase 3)UnknownNCT03944980What this trial is testingStudy of Chemotherapy Combination With Autologous Cell Immunotherapy in the Advanced Lung CancerWho this might be right forIIIB/IIIC/IV Lung Cancer Tianjin Medical University Cancer Institute and Hospital 146
Not applicableStudy completedNCT02728596What this trial is testingS1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)Who this might be right forFebrile NeutropeniaStage 0 Breast CancerStage 0 Colorectal Cancer+25 more SWOG Cancer Research Network 3,665
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Not applicableStudy completedNCT00003329What this trial is testingIdentification of Genes Associated With Cancer in Patients and Siblings Who Have CancerWho this might be right forBreast CancerColorectal CancerLung Cancer+1 more Eastern Cooperative Oncology Group 4,000
Early research (Phase 1)Study completedNCT00019019What this trial is testingCarboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory LymphomasWho this might be right forBrain and Central Nervous System TumorsBreast CancerKidney Cancer+6 more National Institutes of Health Clinical Center (CC) 70
Large-scale testing (Phase 3)UnknownNCT03952403What this trial is testingHLX10 in Combination With Carboplatin Plus (+) Pemetrexed With or Without HLX04 Compared With Carboplatin+Pemetrexed in 1L Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC)Who this might be right forCarcinomaNon-Small-Cell Lung Shanghai Henlius Biotech 643
Large-scale testing (Phase 3)Ended earlyNCT04427072What this trial is testingStudy of Capmatinib Efficacy in Comparison With Docetaxel in Previously Treated Participants With Non-small Cell Lung Cancer Harboring MET Exon 14 Skipping MutationWho this might be right forCarcinoma, Non-Small-Cell Lung Novartis Pharmaceuticals 22
Testing effectiveness (Phase 2)Study completedNCT00003565What this trial is testingDocetaxel in Treating Patients With Solid TumorsWho this might be right forBladder CancerBreast CancerHead and Neck Cancer+2 more Alliance for Clinical Trials in Oncology 109
Not applicableStudy completedNCT00303914What this trial is testingStudy of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal CancerWho this might be right forBreast CancerCognitive/Functional EffectsColorectal Cancer+4 more Eastern Cooperative Oncology Group 2,310
Not applicableLooking for participantsNCT06634199What this trial is testingStudy of Antitumor Immune Response After cCRT and IO Treatment in Non-resectable III Stage NSCLC PatientsWho this might be right forNon-small Cell Lung Cancer Stage IIIPDL1 Gene Mutation Fundación GECP 50
Testing effectiveness (Phase 2)Looking for participantsNCT07309952What this trial is testingNeoadjuvant SBRT Followed by Sintilimab Plus Chemotherapy for N3-Positive NSCLCWho this might be right forLocally Advanced Non-Small Cell Lung CancerStage IIIb Non-small Cell Lung CancerStage IIIC Non-Small Cell Lung Cancer Yang Hong 28
Not applicableStudy completedNCT00897442What this trial is testingCollecting Tumor Samples From Patients With Gynecological TumorsWho this might be right forBorderline Ovarian Clear Cell TumorBorderline Ovarian Serous TumorCervical Adenocarcinoma+83 more Gynecologic Oncology Group 275
Testing effectiveness (Phase 2)Ended earlyNCT00470548What this trial is testingAbraxane and Alimta in Advanced Solid TumorsWho this might be right forBreast CancerLung CancerUnspecified Adult Solid Tumor, Protocol Specific University of California, Davis 49
Early research (Phase 1)UnknownNCT03987867What this trial is testingStudy of Autologous CIK Cell Immunotherapy Combination With PD-1 Inhibitor and Chemotherapy in the Advanced NSCLCWho this might be right forNon-small Cell Lung CancerFirst-line Treatment Tianjin Medical University Cancer Institute and Hospital 30